Literature DB >> 11096080

A Role of RNA Helicase A in cis-Acting Transactivation Response Element-mediated Transcriptional Regulation of Human Immunodeficiency Virus Type 1.

R Fujii1, M Okamoto, S Aratani, T Oishi, T Ohshima, K Taira, M Baba, A Fukamizu, T Nakajima.   

Abstract

RNA helicase A (RHA) has two double-stranded (ds) RNA-binding domains (dsRBD1 and dsRBD2). These domains are conserved with the cis-acting transactivation response element (TAR)-binding protein (TRBP) and dsRNA-activated protein kinase (PKR). TRBP and PKR are involved in the regulation of HIV-1 gene expression through their binding to TAR RNA. This study shows that RHA also plays an important role in TAR-mediated HIV-1 gene expression. Wild-type RHA preferably bound to TAR RNA in vitro and in vivo. Overexpression of wild type RHA strongly enhanced viral mRNA synthesis and virion production as well as HIV-1 long terminal repeat-directed reporter (luciferase) gene expression. Substitution of lysine for glutamate at residue 236 in dsRBD2 (RHA(K236E)) reduced its affinity for TAR RNA and impaired HIV-1 transcriptional activity. These results indicate that TAR RNA is a preferred target of RHA dsRBDs and that RHA enhances HIV-1 transcription in vivo in part through the TAR-binding of RHA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11096080     DOI: 10.1074/jbc.M006892200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Coordinate roles of Gag and RNA helicase A in promoting the annealing of formula to HIV-1 RNA.

Authors:  Li Xing; Chen Liang; Lawrence Kleiman
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

2.  DHX9 pairs with IPS-1 to sense double-stranded RNA in myeloid dendritic cells.

Authors:  Zhiqiang Zhang; Bin Yuan; Ning Lu; Valeria Facchinetti; Yong-Jun Liu
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

3.  The 5' UTR of HIV-1 full-length mRNA and the Tat viral protein modulate the programmed -1 ribosomal frameshift that generates HIV-1 enzymes.

Authors:  Johanie Charbonneau; Karine Gendron; Gerardo Ferbeyre; Léa Brakier-Gingras
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

4.  In vitro and in vivo analysis of the interaction between RNA helicase A and HIV-1 RNA.

Authors:  Li Xing; Meijuan Niu; Lawrence Kleiman
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

5.  A novel domain within the DEAD-box protein DP103 is essential for transcriptional repression and helicase activity.

Authors:  Xiaomei Yan; Jean-François Mouillet; Qinglin Ou; Yoel Sadovsky
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

6.  Cellular RNA Helicase DHX9 Interacts with the Essential Epstein-Barr Virus (EBV) Protein SM and Restricts EBV Lytic Replication.

Authors:  Wenmin Fu; Dinesh Verma; Ashlee Burton; Sankar Swaminathan
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

7.  Dual roles of RNA helicase A in CREB-dependent transcription.

Authors:  S Aratani; R Fujii; T Oishi; H Fujita; T Amano; T Ohshima; M Hagiwara; A Fukamizu; T Nakajima
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

8.  Structural insights reveal the specific recognition of roX RNA by the dsRNA-binding domains of the RNA helicase MLE and its indispensable role in dosage compensation in Drosophila.

Authors:  Mengqi Lv; Yixiang Yao; Fudong Li; Ling Xu; Lingna Yang; Qingguo Gong; Yong-Zhen Xu; Yunyu Shi; Yu-Jie Fan; Yajun Tang
Journal:  Nucleic Acids Res       Date:  2019-04-08       Impact factor: 16.971

9.  Identification of RNA helicase A as a new host factor in the replication cycle of foot-and-mouth disease virus.

Authors:  Paul Lawrence; Elizabeth Rieder
Journal:  J Virol       Date:  2009-08-26       Impact factor: 5.103

10.  RNA helicase A modulates translation of HIV-1 and infectivity of progeny virions.

Authors:  Cheryl Bolinger; Amit Sharma; Deepali Singh; Lianbo Yu; Kathleen Boris-Lawrie
Journal:  Nucleic Acids Res       Date:  2009-12-09       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.